Cancer News: Prostate

Common prostate cancer treatment linked to dementia

Prostate cancer patients treated with testosterone-lowering drugs are more likely to develop dementia.

Brachytherapy alone causes less side-effects in mid-risk prostate cancer

Brachytherapy alone can give similar results & fewer side-effects in mid-risk prostate cancer compared to its combination with external beam therapy (EBT).

Accelerated radiotherapy equivalent to conventional for prostate cancer

Oncology trials show similar outcomes and side effects for early stage prostate cancer with conventional and hypo-fractionated radiotherapy.

Is joint decision making crucial for prostate cancer patients?

A randomized trial proved the importance of joint decision making between prostate cancer patients and physicians during the treatment selection process.

Comparing robotic vs. non-robotic surgery for prostate cancer

Prostate cancer patients undergoing robotic surgery experienced similar quality of life compared to those undergoing open surgery, a trial reveals.

Radical treatment increased survival in prostate cancer patients

Very high-risk prostate cancer patients treated with a high proportion of radical local treatment survived longer, according to a new study.

No benefit from cabozantinib in prostate cancer trial

The inhibitor cabozantinib failed to induce significant benefit in prostate cancer patients, a phase 3 trial reveals.

A diagnosis of high cholesterol led to increased cancer survival

A diagnosis of high cholesterol led to reduced mortality and improved survival in lung, breast, prostate and bowel cancer, a new researches reveals.

Treatment combination prolonged life in prostate cancer

Adding radiotherapy to androgen deprivation therapy in the treatment of metastatic prostate cancer patients prolonged survival more, an analysis reveals.

How can robotic surgery benefit obese prostate cancer patients?

Robotic surgery to remove the prostate reduced risk of blood loss in obese prostate cancer patients, a new study reveals.

Patient-physician communication crucial in prostate cancer

Prostate cancer patients who had a healthy communication with their physicians improved their health-related quality of life, according to a study.

Testosterone therapy: not linked to aggressive prostate cancer risk

Physicians should not hesitate to prescribe testosterone therapy to men as it will not increase their risk of prostate cancer, a new study shows.

Physical activity improved prognosis in prostate cancer

Moderate to high level of physical activity may improve survival prognosis of prostate cancer patients, a new study reports.

A noninvasive form of radiation brings hope in prostate cancer

Treating prostate cancer patients with stereotactic body radiation (SBRT) therapy induced positive results, a new study reveals.

ADT plus bevacizumab show promise in prostate cancer

Prostate cancer patients treated with short-course androgen deprivation therapy plus bevacizumab had a longer relapse-free interval, a small study shows.

Shorter and intensive radiotherapy: safe in early prostate cancer

Early-stage prostate cancer patients can be given a shorter and slightly higher daily dose of radiation with no difference in overall survival, a study shows.

Survival benefit in prostate cancer with abiraterone acetate

Abiraterone acetate increased overall survival in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer.

Location of prostate cancer metastasis affects survival

A new large study reported that the location where prostate cancer spreads has an impact on the patient’s survival time.

Guidelines for active surveillance in low-risk prostate cancer

A report on active surveillance of low-risk prostate cancer patients clarifies who should undergo "active surveillance” instead of prostatectomy or radiation.

Docetaxel to be funded by NHS England for advanced prostate cancer

Docetaxel chemotherapy will be made available to newly diagnosed advanced prostate cancer patients in England, the NHS has announced.

Enzalutamide appears effective in metastatic prostate cancer

A study comparing enzalutamide to bicalutamide in castration-resistant prostate cancer showed that enzalutamide increased significantly progression-free survival.

Positive outcomes coming from a drug sequencing in prostate cancer

Treating patients with castration-resistant metastatic prostate cancer with docetaxel following abiraterone resulted in a 50% reduction in prostate specific antigen.

Improved survival in prostate cancer with combination treatment

Treating high-risk prostate cancer patients with anti-androgen therapy using daily bicalutamide improved their overall survival, a new research reveals.

Chemical or surgical castration for prostate cancer?

A study comparing surgical to chemical castration in men with metastatic prostate cancer showed that surgical castration leads to less adverse effects.

Is watchful waiting really included in prostate cancer management?

Scientists reveal that very few low-risk prostate cancer patients followed by watchful waiting are closely monitored as called for in current guidelines.

Soccer counters prostate cancer treatment-related side effects

Prostate cancer patients playing soccer a few times a week improved muscular strength and bone density, tackling treatment-related side effects.

The benefits of yoga for prostate cancer patients

Taking intensive yoga classes helped patients undergoing prostate cancer treatment improve their general well-being, a new research shows.

Gene-targeted drug against prostate cancer

Olaparib, a drug against inherited cancer mutations, was found to benefit as many as a third of patients with prostate cancer, a new study reveals.

A more convenient treatment for low-risk prostate cancer patients

A shorter radiation therapy schedule was equally beneficial as a longer treatment schedule for some men with low-risk prostate cancer.

Do prostate cancer patients need treatment at all?

A new long-term study showed that treatment was unnecessary for the majority of older men diagnosed with low-risk prostate cancer and under an active surveillance scheme.

Login to your account

Did you forget your password?